These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1608666)

  • 41. Bacteriological study of Neisseria strains isolated in Romania 1971-1992.
    Leveneţ I; Paşolescu O; Mihalcu F; Gulan L; Dorobăţ O; Lucinescu S; Iacob A
    Roum Arch Microbiol Immunol; 1993; 52(2):121-9. PubMed ID: 8186455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphonamide-susceptibility of meningococci isolated from patients in the Netherlands, before, during and after an epidemic of meningococcal disease.
    Severin WP; Ruys AC; Butter MN; Walig C
    Zentralbl Bakteriol Orig; 1969; 211(2):198-205. PubMed ID: 4989402
    [No Abstract]   [Full Text] [Related]  

  • 43. [Meningococcal infections: aspects of microbiology, epidemiology and prevention].
    Ehrhard I; Sonntag HG
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S41-5. PubMed ID: 10593044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meningococcal disease in Italy.
    Stroffolini T; Congiu ME; Occhionero M; Mastrantonio P
    J Infect; 1989 Jul; 19(1):69-74. PubMed ID: 2506286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Characterization of Neisseria meningitidis strains isolated from carriers].
    Grzybowska W; Tyski S
    Med Dosw Mikrobiol; 2000; 52(3):257-66. PubMed ID: 11147267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
    Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S
    Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two serologically non-groupable Neisseria meningitidis strains from clinical specimens identified by molecular method as serogroup B meningococci.
    Tsang RS; Law D; Squires SG
    Can Commun Dis Rep; 2001 Jan; 27(1):9-12. PubMed ID: 11195965
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter: Meningitis chemoprophylaxis.
    J Miss State Med Assoc; 1975 Dec; 16(12):384. PubMed ID: 811806
    [No Abstract]   [Full Text] [Related]  

  • 50. Nasopharyngeal carriage of Neisseria meningitidis in the contacts of index cases of meningococcal meningitis.
    Ichhpujani RL; Singh T; Kumari S; Basu RN
    J Commun Dis; 1986 Mar; 18(1):1-5. PubMed ID: 3091676
    [No Abstract]   [Full Text] [Related]  

  • 51. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin.
    Cooper ER; Ellison RT; Smith GS; Blaser MJ; Reller LB; Paisley JW
    J Pediatr; 1986 Jan; 108(1):93-6. PubMed ID: 3080574
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemoprophylaxis for the prevention of bacterial meningitis.
    Schaad UB
    Infection; 1984; 12 Suppl 1():S65-71. PubMed ID: 6530293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meningococcal meningitis.
    Sohal AS; Rao VR
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1471-2. PubMed ID: 3132305
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serotyping and subtyping strains of Neisseria meningitidis isolated from patients in Czechoslovakia 1975-1986].
    Kuzemenská P; Bobák M
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):78-87. PubMed ID: 2142626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
    Blakebrough IS; Gilles HM
    J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic and antigenic characterization of Neisseria meningitidis strains from Turkish recruits in 2006.
    Kilic A; Jolley KA; Gul HC; Saracli MA; Besirbellioglu B; Basustaoglu AC
    Intern Med; 2008; 47(21):1949-50. PubMed ID: 18981645
    [No Abstract]   [Full Text] [Related]  

  • 60. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.